Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (43)

• Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis via openalex
• Comparison of c-DNA microarray analysis of gene expression between eutopic endometrium and ectopic endometrium (endometriosis) via openalex
• Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis via openalex
• Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis via openalex
• Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2 via openalex
• Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9 via openalex
• Immunohistochemical detection of heparanase-1 expression in eutopic and ectopic endometrium from women with endometriosis via openalex
• Increased invasion activity of endometrial stromal cells and elevated expression of matrix metalloproteinase messenger RNA in the uterine tissues of mice with experimentally induced adenomyosis via openalex
• Matrix Metalloproteinase-2 and -9 Expression Correlated with Angiogenesis in Human Adenomyosis via openalex
• Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium via openalex
• Matrix Metalloproteinases and Endometriosis via openalex
• Pathophysiology of adenomyosis via openalex
• Progesterone Receptor Isoform A But Not B Is Expressed in Endometriosis via openalex
• Uterus and endometrium: Inhibition of human endometrial stromal cell proliferation by interleukin 6 via openalex
• W2048202756 via openalex
• W2013885896 via openalex
• W2061951366 via openalex
• W2065504014 via openalex
• W1993638899 via openalex
• W2077483002 via openalex
• W1992880469 via openalex
• W1991222851 via openalex
• W2092843143 via openalex
• W1979390430 via openalex
• W2107713440 via openalex
• W2110264098 via openalex
• W1977127210 via openalex
• W2133376231 via openalex
• W2136084194 via openalex
• W1619424648 via openalex
• W1582325190 via openalex
• W1503337666 via openalex
• W2152447862 via openalex
• W2154377312 via openalex
• W2156052810 via openalex
• W2170134994 via openalex
• W2406818453 via openalex
• W2411537421 via openalex
• W2468339367 via openalex
• W6636607757 via openalex
• W6658221620 via openalex
• W6680090005 via openalex
• W6714506140 via openalex

Cited by (24)

• Shared Biology Underlying Benign Endometrial Diseases and Endometrial Cancer: Current Knowledge and Future Prospectives 2026
• MMP2/TIMP2 ratio as a measurable indicator for differentiating diffuse adenomyosis, ovarian endometriosis, and their co-existence 2025
• Protective Effect of Ursodeoxycholic Acid in Experimental Endometriosis Induced Rat Model 2023
• Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development 2022
• Physiomimetic Models of Adenomyosis 2020
• An Update on the Various Theories of the Origin of Uterine Adenomyosis –A Systematic Review 2020
• Abnormal expression of connective tissue growth factor and its correlation with fibrogenesis in adenomyosis 2020
• Uterine Stem Cells and Benign Gynecological Disorders: Role in Pathobiology and Therapeutic Implications 2020
• Benign Uterine Diseases 2019
• Pathogenesis of uterine adenomyosis: invagination or metaplasia? 2018
• Berberine inhibits the LPS‑induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway 2017
• Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis 2016
• Ultramicro-trauma in the endometrial-myometrial junctional zone and pale cell migration in adenomyosis 2015
• Effect of warming Yang and removing blood stasis method on matrix metalloproteinases / tissue inhibitor metalloproteinases levels secreted by cultured endometrial cells from patients with endometriosis 2015
• Increased expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells 2015
• The Pathophysiology of Adenomyosis 2015
• The Endometrium in Adenomyosis 2015
• TNF<i>α</i> and IL1<i>β</i> Stimulate Differential Gene Expression in Endometrial Stromal Cells 2015
• Moesin overexpression is a unique biomarker of adenomyosis 2014
• The motile and invasive capacity of human endometrial stromal cells: implications for normal and impaired reproductive function 2013
• The Endometrium in Adenomyosis 2012
• The pathophysiology of uterine adenomyosis: an update 2012
• Differential immunohistochemical expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in cow uteri with adenomyosis during follicular phase 2011
• 异常在位子宫内膜是内异症的病因吗？-在位内膜在内异症发病中的作用 2011

Source provenance

europepmc

last seen: 2026-06-11T06:19:48.454388+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:14:30.652814+00:00